Lauren
Angelilli

Ms. Angelilli’s experience encompasses a wide range of matters and transaction types. She regularly advises clients in connection with:

• Significant M&A transactions, including for Anheuser-Busch InBev in its $123 billion acquisition of SABMiller; Disney in its $85 billion acquisition of 21st Century Fox; H.J. Heinz and 3G Capital in Heinz’s $60 billion merger with Kraft Foods Group; Occidental Petroleum in its $57 billion acquisition of Anadarko, topping Anadarko’s original agreement with Chevron; and Time Warner in its $109 billion sale to AT&T
• Spin-offs, split‑offs and public listings, including for Ashland in the IPO and tax‑free separation of its Valvoline business; DreamWorks Animation in its IPO; Graham Holdings in the spin‑off of Cable One; Honeywell in the spin‑off of its Resins and Chemicals business into a new independent public company, AdvanSix; Sprint in its spin‑off of EMBARQ; Time Warner in its spin‑offs of Time Inc., AOL and Time Warner Cable and the split‑off of the Atlanta Braves to Liberty Media; White Mountains Insurance in its split‑off of certain insurance businesses to General Reinsurance; and Xerox in the spin‑off of Conduent
• Special committee and board of director matters, including for Endeavor’s special committee in the pending $25 billion take‑private acquisition by Silver Lake; the special committee of the Hudson board of directors in the sale of all remaining equity interests in Hudson to Dufry; Paramount’s special committee in the pending $28 billion merger with Skydance; Viacom’s board committee in the $30 billion merger with CBS; Yahoo’s board committee in the $4.48 billion acquisition of Yahoo’s operating business by Verizon; and the special committee of the board of Eidos Therapeutics in the $2.83 billion merger with BridgeBio Pharma
• Complex private equity transactions, including for the founders of Alliance Animal Health in the significant growth investment from L Catterton; Aras in its substantial growth investment from GI Partners; Atlas Air in its $5.2 billion acquisition by an investor group led by Apollo; Brookfield and its affiliates in Brookfield Reinsurance’s $4.3 billion acquisition of American Equity Investment Life and Brookfield Renewable’s $2.8 billion acquisition of Duke Energy Renewables; Cable One in the formation of Clearwave Fiber, a joint venture with GTCR, Stephens Capital Partners and The Pritzker Organization; and J.D. Power in its sale to Thoma Bravo

Ms. Angelilli has represented clients across a diverse range of industry sectors, with significant depth in technology, media and telecommunications, as well as biotechnology and life sciences. Notable matters include representing:

Technology

• Afterpay in its $29 billion acquisition by Block
• J.D. Power in its sale to Thoma Bravo
• Pitney Bowes in the $700 million sale of its Software Solutions business to Syncsort, its $475 million acquisition of Newgistics and its $395 million acquisition of Borderfree
• Technicolor in the $475 million sale of its Patent Licensing business to InterDigital
• Xerox in the $1.05 billion sale of its information technology outsourcing business to Atos and the spin‑off of Conduent
• Yahoo’s board committee in the $4.48 billion acquisition of Yahoo’s operating business by Verizon

Media and Entertainment

• Amblin Partners in the exit of Participant as an equity holder and NBCUniversal’s re‑investment; its strategic partnership with Alibaba Pictures; and, together with Steven Spielberg, in its formation with Participant Media, Reliance Entertainment and Entertainment One
• Disney in its $85 billion acquisition of 21st Century Fox, overcoming an interloper bid by Comcast to its original $66 billion agreement; the $10.6 billion sale of the Fox Regional Sports Networks to Sinclair; the $3.47 billion sale of its interest in the YES Network to an investor group including the Yankees and Sinclair; the pending combination of its Hulu + Live TV business with Fubo; ESPN’s proposed joint venture with Fox and Warner Bros. Discovery to launch Venu Sports; ESPN’s strategic alliance with PENN Entertainment to launch ESPN BET; Endemol Shine’s acquisition by Banijay Group; the sale of FoxNext Games to Scopely; and the sale of a majority stake in Fox TeleColombia & Estudios TeleMexico to ViacomCBS
• DreamWorks Animation in a number of matters, including its IPO, the formation of Oriental DreamWorks and its $4.1 billion sale to Comcast
• Endeavor’s special committee in the pending $25 billion take‑private acquisition by Silver Lake
• Paramount’s special committee in the pending $28 billion merger with Skydance
• Quibi in its $750 million Series C private financing, the sale of its global content distribution rights to Roku and its out‑of‑court wind‑down process
• Time Warner in its $109 billion sale to AT&T; its investment in Hulu; and its spin-offs of Time Inc., AOL and Time Warner Cable and the split‑off of the Atlanta Braves to Liberty Media
• Viacom’s board committee in the $30 billion merger with CBS

Telecommunications

• Bharti in the acquisition of, and $1 billion investment in, OneWeb by a consortium led by Bharti and Her Majesty’s Government
• Cable One in its $2.2 billion acquisition of Hargray Communications; its $735 million acquisition of NewWave Communications; its $525.9 million acquisition of Fidelity Communications’ data, video and voice business; its acquisition of Clearwave Communications; the formation of Clearwave Fiber, a joint venture with GTCR, Stephens Capital Partners and The Pritzker Organization; and its strategic partnership with Mega Broadband
• EMBARQ in its acquisition by CenturyTel
• Graham Holdings in the spin‑off of Cable One
• Sprint in its merger with Nextel Communications and later spin-off of EMBARQ

Biotechnology, Life Sciences and Healthcare

• AmerisourceBergen in its $6.5 billion acquisition of Walgreens’ Alliance Healthcare businesses and its strategic relationship with Walgreens and Alliance Boots
• AveXis in its $8.7 billion acquisition by Novartis
• Biogen in its $7.3 billion acquisition of Reata Pharmaceuticals
• Cano Health shareholders, including members of management, in the $4.4 billion SPAC merger with Jaws Acquisition Corp., which included an $800 million PIPE investment
• The special committee of the board of Eidos Therapeutics in the $2.83 billion merger with BridgeBio Pharma
• Global Blood Therapeutics in its $5.4 billion acquisition by Pfizer
• HCSC in its pending $3.3 billion acquisition of Cigna’s Medicare businesses and CareAllies
• Shire in its $32 billion combination with Baxalta
• Thermo Fisher Scientific in its $20.9 billion acquisition of PPD and its $3.1 billion acquisition of Olink

Financial Services and Insurance

• Aon in its $13 billion acquisition of NFP
• Brookfield Reinsurance in its $4.3 billion acquisition of American Equity Investment Life

Consumer and Retail

• Anheuser-Busch InBev in its $123 billion acquisition of SABMiller and the $12 billion sale of SABMiller’s U.S. and global Miller‑branded businesses to Molson Coors
• Bacardi in its acquisition of ILEGAL Mezcal
• H.J. Heinz and 3G Capital in Heinz’s $60 billion merger with Kraft Foods Group to form The Kraft Heinz Company
• The special committee of the Hudson board of directors in the sale of all remaining equity interests in Hudson to Dufry
• Starbucks in its acquisition of Teavana, its commercial arrangement with Oprah Winfrey and its investment in Square
• Starwood Hotels in its $13.3 billion sale to Marriott International
• Unilever in its acquisition of a majority stake in Nutrafol

Energy, Infrastructure and Industrials

• Altra in its $5 billion acquisition by Regal Rexnord, the $3 billion “Reverse Morris Trust” combination with Fortive’s Automation and Specialty platform and the $325 million sale of its Jacobs Vehicle Systems business to Cummins
• The Aquarion Water Authority in its pending $2.4 billion acquisition of Aquarion Water Company from Eversource Energy
• Ashland in the $1.8 billion sale of Ashland Water Technologies to Clayton, Dubilier & Rice, the $1.65 billion sale of its performance adhesives business to Arkema, its $660 million acquisition of Pharmachem, the IPO and tax‑free separation of its Valvoline business and the sale of its nutraceuticals business to Turnspire Capital Partners
• Brookfield Renewable in its $2.8 billion acquisition of Duke Energy Renewables
• Honeywell in its proposed $90 billion acquisition of United Technologies, the $300 million sale of Honeywell Technology Solutions and the spin‑off of its Resins and Chemicals business into a new independent public company, AdvanSix
• Occidental Petroleum in its $57 billion acquisition of Anadarko, topping Anadarko’s original agreement with Chevron; the $10 billion investment from Berkshire Hathaway; and the $8.8 billion sale of Anadarko’s African assets to Total
• RWE in its $6.8 billion acquisition of the Con Edison Clean Energy Businesses

Transportation

• Atlas Air in its $5.2 billion acquisition by an investor group led by Apollo
• Canadian National Railway in its proposed $33.6 billion combination with Kansas City Southern
• Delta Air Lines in its acquisition of 49% of Virgin Atlantic from Singapore Airlines and in Delta’s related trans‑Atlantic joint venture with Virgin
• UAL in its merger of equals with Continental Airlines, creating United Continental Holdings

Ms. Angelilli has been repeatedly cited as a leading tax practitioner by, among others, Chambers USA, The Legal 500 US and The Best Lawyers in America. She has been named a “Tax MVP” and was selected to the “Influential Women in Tax Law” list by Law360. Ms. Angelilli has also been named to the list of “Leading Women Lawyers in New York City” by Crain’s New York Business and was named “Best in Tax” by Euromoney Legal Media Group’s Americas Women in Business Law Awards. Additionally, Ms. Angelilli has been recognized by Lawdragon as among the “500 Leading Lawyers in America” and the “500 Leading Dealmakers in America.”

Ms. Angelilli was born in New York, New York. She received a B.S. magna cum laude from the Wharton School of the University of Pennsylvania in 1996 and a J.D. cum laude from Harvard Law School in 2000.

Ms. Angelilli joined Cravath in 2000 and was elected a partner in 2007.